Rescue of chemorefractory classical Hodgkin lymphoma with nivolumab and autologous stem-cell transplantation: Real-life experience

被引：0
|
作者：
Buccheri, Valeria [1 ,2 ]
Fatobene, Giancarlo [1 ,3 ]
Santos, Fernanda M. [2 ]
Velasques, Rodrigo D. [2 ]
Bellesso, Marcelo [2 ]
Atanazio, Marcelo J. [1 ,2 ]
Rocha, Vanderson [1 ,2 ,3 ]
机构：
[1] Univ Sao Paulo, Fac Med, Hosp Clin, Div Hematol, Sao Paulo, Brazil
[2] Inst Canc Estado Sao Paulo, Hematol Div, Sao Paulo, Brazil
[3] Hosp Sirio Libanes, Div Oncol, Sao Paulo, Brazil
来源：
HEMATOLOGICAL ONCOLOGY | 2021年 / 39卷 / 01期
关键词：
RESPONSE ASSESSMENT; MULTICOHORT; FAILURE;
D O I：
10.1002/hon.2796
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：134 / 136
页数：3
相关论文
共 50 条
  • [1] The role of autologous stem-cell transplantation in classical Hodgkin lymphoma in the modern era
    Varma, Gaurav
    Diefenbach, Catherine
    SEMINARS IN HEMATOLOGY, 2024, 61 (04) : 253 - 262
  • [2] Real-Life Experience of Nivolumab in Heavily Pretreated Relapsed and Refractory Classical Hodgkin Lymphoma
    Benjamini, Ohad
    Lavie, David
    Dann, Eldad J.
    Perry, Chava
    Rouvio, Ory
    Shvetz, Olga
    Nemets, Anatoly
    Perets, Ruth
    Saban, Revital
    Shimoni, Avichai
    Ben-Yehuda, Dina
    Nagler, Arnon
    Avigdor, Abraham
    BLOOD, 2016, 128 (22)
  • [3] Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience
    Bekoz, Huseyin
    Ozbalak, Murat
    Karadurmus, Nuri
    Paydas, Semra
    Turker, Alev
    Toptas, Tayfur
    Tuglular, Tulin Firatli
    Altuntas, Fevzi
    Cakar, Merih Kizil
    Sonmez, Mehmet
    Gulbas, Zafer
    Demir, Nazli
    Kaynar, Leylagul
    Yildirim, Rahsan
    Karadogan, Ihsan
    Arat, Mutlu
    Kapucu, Irem
    Aslan, Nevin Alayvaz
    Ozkocaman, Vildan
    Turgut, Mehmet
    Yuksel, Meltem Kurt
    Ozcan, Muhit
    Hacioglu, Sibel Kabukcu
    Barista, Ibrahim
    Demirkaya, Metin
    Saydam, Guray
    Toprak, Selami K.
    Yilmaz, Mehmet
    Demirkol, Onur
    Ferhanoglu, Burhan
    ANNALS OF HEMATOLOGY, 2020, 99 (11) : 2565 - 2576
  • [4] Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience
    Huseyin Bekoz
    Murat Ozbalak
    Nuri Karadurmus
    Semra Paydas
    Alev Turker
    Tayfur Toptas
    Tülin Firatli Tuglular
    Fevzi Altuntas
    Merih Kizil Cakar
    Mehmet Sonmez
    Zafer Gulbas
    Nazlı Demir
    Leylagul Kaynar
    Rahsan Yildirim
    Ihsan Karadogan
    Mutlu Arat
    Irem Kapucu
    Nevin Alayvaz Aslan
    Vildan Ozkocaman
    Mehmet Turgut
    Meltem Kurt Yuksel
    Muhit Ozcan
    Sibel Kabukcu Hacioglu
    Ibrahim Barista
    Metin Demirkaya
    Guray Saydam
    Selami K. Toprak
    Mehmet Yilmaz
    Onur Demirkol
    Burhan Ferhanoglu
    Annals of Hematology, 2020, 99 : 2565 - 2576
  • [5] Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience
    Bekoz, H.
    Karadurmus, N.
    Paydas, S.
    Turker, A.
    Toptas, T.
    Tuglular, T. Firatli
    Sonmez, M.
    Gulbas, Z.
    Tekgunduz, E.
    Kaya, A. H.
    Ozbalak, M.
    Tastemir, N.
    Kaynar, L.
    Yildirim, R.
    Karadogan, I.
    Arat, M.
    Tanrikulu, F. Pepedil
    Ozkocaman, V.
    Abali, H.
    Turgut, M.
    Yuksel, M. Kurt
    Ozcan, M.
    Dogu, M. H.
    Hacioglu, S. Kabukcu
    Barista, I.
    Demirkaya, M.
    Koseoglu, F. D.
    Toprak, S. K.
    Yilmaz, M.
    Demirkurek, H. C.
    Demirkol, O.
    Ferhanoglu, B.
    ANNALS OF ONCOLOGY, 2017, 28 (10) : 2496 - 2502
  • [6] Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience
    Massaro, Fulvio
    Pavone, Vincenzo
    Stefani, Piero Maria
    Botto, Barbara
    Pulsoni, Alessandro
    Patti, Caterina
    Cantonetti, Maria
    Visentin, Andrea
    Scalzulli, Potito Rosario
    Rossi, Andrea
    Galimberti, Sara
    Cimminiello, Michele
    Gini, Guido
    Musso, Maurizio
    Sorio, Marco
    Arcari, Annalisa
    Zilioli, Vittorio Ruggero
    Luppi, Mario
    Mannina, Donato
    Fabbri, Alberto
    Pietrantuono, Giuseppe
    Annibali, Ombretta
    Tafuri, Agostino
    Prete, Eleonora
    Mule, Antonino
    Barbolini, Elisa
    Marcheselli, Luigi
    Luminari, Stefano
    Merli, Francesco
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (01) : 31 - 39
  • [7] NIVOLUMAB FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA: A REAL-LIFE EXPERIENCE IN CAMPANIA
    Trastulli, F.
    Vitagliano, O.
    Della Pepa, R.
    Giordano, C.
    Rosamilio, R.
    Pezzullo, L.
    Ronconi, F.
    Ferrara, F.
    Pane, F.
    Picardi, M.
    HAEMATOLOGICA, 2019, 104 : 129 - 129
  • [8] Outcome of autologous stem-cell transplantation in Hodgkin and non hodgkin lymphoma patients
    Soyer, N.
    Mutlu, C. Atmaca
    Vural, F.
    Tombuloglu, M.
    Tobu, M.
    Sahin, F.
    Saydam, G.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S289 - S290
  • [9] Outcomes of Refractory and Relapsed Hodgkin Lymphoma With Autologous Stem-Cell Transplantation: A Single Institution Experience
    Wali, Rabia
    Saeed, Haleema
    Patrus, Naveed
    Javed, Shehla
    Khan, Saadiya Javed
    JOURNAL OF GLOBAL ONCOLOGY, 2019, 5 : 1 - 6
  • [10] Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma
    Chan, Fong Chun
    Mottok, Anja
    Gerrie, Alina S.
    Power, Maryse
    Nijland, Marcel
    Diepstra, Arjan
    van den Berg, Anke
    Kamper, Peter
    d'Amore, Francesco
    d'Amore, Alexander Lindholm
    Hamilton-Dutoit, Stephen
    Savage, Kerry J.
    Shah, Sohrab P.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Scott, David W.
    Steidl, Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (32) : 3722 - +
12345